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Abstract
Reusing intravaginal devices represents an important alternative to reduce costs; however, this practice may
increase disease transmission. The aim of this study was to evaluate the efficacy of reusing autoclaved
intravaginal progesterone devices for oestrous synchronization in Toggenburg goats in the breeding season
was studied. This study was done in March and April of 2009, in Piau, MG, Brazil (latitude 21°35′ and
longitude 43°15′). Sixty-seven Toggenburg nulliparous (n = 17; 35.3 ± 5.4 kg and 3.3 ± 0.2) and pluriparous
(n = 50; 52.9 ± 9.8 kg and 3.4 ± 0.3) goats were assigned according to weight and body condition score (BCS,
1 to 5 scale) into 3 treatments. Animals received new devices (n = 25; 48.2 ± 11.5 kg and BCS 3.4 ± 0.3)
containing 0.33 g of progesterone (Eazi-Breed CIDR®, Pfizer Animal Health, São Paulo, Brazil) or
autoclaved (121°C, 1 atm, 15 min) devices previously used for 6 days (n = 23; 48.3 ± 13.0 kg and 3.5 ± 0.3)
or 12 days (n = 22; 48.2 ± 11.0 kg and 3.4 ± 0.3). All goats received 5 mg dinoprost (Lutalyse®, Pfizer
Animal Health) in the vulvar submucosa on the day of CIDR insertion (Day 0) and 200 IU eCG (Novormon
5000®, Sintex Indústria Bioquímica, Buenos Aires, Argentina) 1 day before CIDR removal, also in the vulvar
submucosa. The CIDR were removed on day 6, and goats were bred twice daily with fertile bucks at oestrous
onset and 24 h later if they were still in oestrus. Parametric variables were analysed by ANOVA and SNK
tests by the SAEG® program. Nonparametric variables were analysed using the chi-square test by the
BioEstat® program. The results are described as mean ± SD. Oestrous response and conception rates did not
differ (P > 0.05) among goats treated with the new devices (75.0; 54.2%) or those previously used for 6 (81.8;
50.0%) or 12 days (71.4; 47.6%), respectively. No differences were detected between nulliparous (82.3;
52.9%) and pluriparous (72.0; 50.0%) goats. The interval from device removal to oestrus and duration of
oestrus were not different (P > 0.05) among animals receiving a new device (39.3 ± 15.8; 30.7 ± 16.6 h) or
previously used devices for 6 (32.7 ± 11.5; 31.8 ± 7.3 h) or 12 day (40.8 ± 20.7; 32.8 ± 13.2 h) treatments,
respectively, or between nulliparous (41.6 ± 14.9; 30.9 ± 13.9 h) and pluriparous (35.6 ± 16.8; 32.1 ± 12.8 h)
goats. Since no differences were detected in the evaluated variables among goats receiving reused autoclaved
devices or new ones, it can be suggested that the autoclaving process did not affect the efficiency of reusing
intravaginal progesterone devices for oestrous synchronization in Toggenburg goats in the breeding season.
Probably, P4 concentrations in goats receiving reused autoclaved devices reached at least minimum
concentrations to promote oestrous response, since a non-treated group would not show oestrus in this level of
synchronization as in goats in this study. This technique can be a simple and valuable tool to reduce sanitary
risks of disease transmission without altering fertility in goats.
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